HOUSTON—Hill Kirby (NYSE: ), President of Industry Solutions at Skyward Specialty Insurance Group, Inc. (NASDAQ:SKWD), recently sold a portion of his holdings in the company. According to a filing with the Securities and Exchange Commission, Kirby sold 1,560 shares of Skyward Specialty common stock on Jan. 2, at a weighted average price of $49.004 per share. The total transaction value was $76,446. The sale comes as the stock, which currently trades at $45.09, has experienced a notable 10.8% decline over the past week, according to InvestingPro data.

This sale was executed under a Rule 10b5-1 trading plan adopted by Kirby on August 8, 2024. The transaction is part of a series of sales made to cover taxes and fees associated with a vesting event in Restricted Stock Award granted to Kirby, which fully vests on January 1, 2025. Despite the recent reduction, InvestingPro The analysis shows that the company maintains a “GREAT” financial health score, with liquid assets in excess of short-term liabilities. For comprehensive insider trading patterns and 8 additional ProTips, check out the full InvestingPro Research Report.

Following this transaction, Kirby will own 8,786 shares of Skyward Specialty common stock, representing a stake in this $1.86 billion market cap company that has delivered a strong 26% return over the past six months.

In other recent news, Palomar Holdings (NASDAQ: ) and Skyward Specialty Insurance Group saw their share price targets revised by Piper Sandler. For Palomar, the target was raised from $119 to $133, maintaining the Overweight rating, reflecting the expectation of a favorable environment for the main insurers in 2025. The revised price target is based on an estimated 19 times the projected earnings per share (EPS) of $6.80 for the year 2026, according to analyst Paul Newsome. However, Newsome noted potential risks due to Palomar’s focus on niche business lines that could be influenced by competitive changes and regulatory changes.

Meanwhile, Skyward Specialty’s price target was raised to $58 from $54, also maintaining an Overweight rating. The revised target reflects an increased earnings multiple based on the company’s forward earnings estimate of $3.60 per share for 2026. The decision to adjust the price target upward comes as a response to Skyward Specialty of positive performance in recent years, with strong revenue growth reported. Analysts from William Blair, Oppenheimer, and BMO Capital also gave their ratings to Skyward Specialty, citing the company’s strong outlook and potential to continue to exceed earnings forecasts.

These developments provide investors with a snapshot of the recent performance and strategic initiatives of Palomar Holdings and Skyward Specialty Insurance Group.

This article was created with the support of AI and reviewed by an editor. For more information see our T&C.